Emalex Biosciences

company

About

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.

  • 11 - 50

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$15M
Industries
Biopharma,Biotechnology,Health Care,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders. The company's first development candidate Ecopipam, is a novel compound that has been studied as a potential treatment for many central nervous system (CNS) disorders, including pediatric Tourette Syndrome.

Emalex Biosciences was founded in 2018 by Jeff Aronin.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$15M
Emalex Biosciences has raised a total of $15M in funding over 2 rounds. Their latest funding was raised on Jun 3, 2020 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 3, 2020 Debt Financing $15M 1 Horizon Technology Finance Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Emalex Biosciences is funded by 1 investors. Horizon Technology Finance are the most recent investors.
Investor Name Lead Investor Funding Round
Horizon Technology Finance Yes Debt Financing